Find your next paid study

Mitral RegurgitationMitral StenosisMitral Valve Disease+4 more

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT05847569

Abbott Cephea Mitral Valve Disease Registry

The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitr…

Abbott Medical DevicesNCT07069673

~$10 – $1,125

Actual pay is set by the research site.

CancerSolid TumorMelanoma+6 more

A First-In-Human Phase 1/2 Open-Label Study of Intravenous ST-067, Subcutaneous ST-067 with or Without Obinutuzumab Pre-Treatment, and ST-067 in Combination with Pembrolizumab in Subjects with Advanced Solid Malignancies

This is a multiphase, multicenter study, which includes a Phase 1a open-label, dose escalation monotherapy study of ST-067 given as an SC injection with or wit…

Simcha IL-18, Inc.NCT04787042

~$150 – $4,200

Actual pay is set by the research site.

Lung Transplant; Complications

A Prospective, Randomized, Controlled Pilot Study of Early-Use Long Acting Tacrolimus (Envarsus XR) in Lung Transplant Recipients

Lung transplantation is a life-saving therapy for patients with advanced lung disease, however, necessitates the use of life-long immunosuppressive therapy for…

Vanderbilt University Medical CenterNCT04469842

~$150 – $3,000

Actual pay is set by the research site.

Leptomeningeal Metastasis

A Multicenter Phase 1 Study to Determine the Safety and Efficacy of Multiple Doses at Defined Intervals of Rhenium (186Re) Obisbemeda (Rhenium-186 NanoLiposome, 186RNL) Administered Via Intraventricular Catheter for Any Primary Solid Tumor Cancer With Leptomeningeal Metastases

This is an open-label, multicenter, Phase 1 study to determine the safety and efficacy of multiple doses at defined intervals of rhenium (186Re) obisbemeda (rh…

Posttraumatic Stress DisorderMajor Depressive Disorder

~$150 – $4,500

Actual pay is set by the research site.

CerenomeNCT07098806

Observational

Treatment of Stress-Related Psychopathology: Targeting Maladaptive and Adaptive Event Processing

The R33 will be a randomized controlled trial to replicate changes in the targets (unproductive processing, avoidance, reward deficits) from the R61 phase in a…

Case Western Reserve UniversityNCT06093906

~$10 – $750

Actual pay is set by the research site.

Heart FailureIschemic CardiomyopathyICD Patients

An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators

This is a Phase 2 study evaluating the positron-emitting radiopharmaceutical 18F-mFBG as an imaging agent for quantification of myocardial sympathetic innervat…

Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)NCT06965621

~$75 – $2,800

Actual pay is set by the research site.

Emetine for Viral Outbreaks: A Phase 2/3 Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Emetine for Dengue Fever (a.k.a. EVOLVE Antiviral Initiative)

The goal of this study is to evaluate the efficacy and safety of emetine administered orally for symptomatic patients aged 18-65 years infected with the dengue…

Dengue

Johns Hopkins UniversityNCT07016321

~$75 – $2,000

Actual pay is set by the research site.

Diabetes (DM)Diabetic KetoacidosisKetosis Prone Diabetes+1 more

Phase 1 Randomized Clinical Trial of Arginine Hydrochloride Administration to Reduce Duration of Diabetic Ketoacidosis in Patients With Type 2 Diabetes

Diabetic ketoacidosis (DKA) is increasingly recognized in adults with "ketone-prone" type 2 diabetes. In many of these patients, the pancreas can still make in…

David K CarrollNCT07167693

~$150 – $4,500

Actual pay is set by the research site.

Evaluate Safety and Efficacy of Daily Oral Angelica Gigas Nakai (AGN)-INM176 in Prostate Patients With Rising Plasma PSA (Phase I/II Trial)

This Phase I/II open-label trial aims to evaluate the safety and efficacy of the herbal supplement INM176 in patients with a history of prostate cancer or low-…

Prostate Cancer

Milton S. Hershey Medical CenterNCT06600698

~$150 – $3,000

Actual pay is set by the research site.

The CONQUER Trial: Cessation Of Nicotine, QUitting With E-cigarette Reduction - A Single-Arm, Open-Label Clinical Trial to Assess the Efficacy of VapeAway in Promoting Vaping Cessation Compared to Historical Rates of Vaping Cessation

This clinical trial evaluates the VapeAway system, a novel, multi-modal intervention designed to address the multifaceted nature of vaping addiction. VapeAway …

Addiction Nicotine

~$75 – $3,000

Actual pay is set by the research site.

VapeAwayNCT07322432

A Phase II Prospective Trial Utilizing Short Course Androgen Deprivation Therapy In Conjunction With Ultra-Hypofractionated SBRT For High Risk Nccn Prostate Cancer With Lower Risk Artera Scores

For this study, high risk prostate cancer patients with lower risk ARTERA scores will be treated with 6 months of Androgen Deprivation Therapy (ADT) in conjunc…

Prostate Cancer